Yayınlar & Eserler

Yayın Ağı
Makaleler 37
Tümü (37)
SCI-E, SSCI, AHCI (20)
SCI-E, SSCI, AHCI, ESCI (20)
Scopus (21)
TRDizin (13)
Diğer Yayınlar (6)

1. Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study

ERSOY M., KEFELİ U., ÇABUK D., BAYRAM E., Bayir D., BOZKURT O., et al.
Frontiers in Immunology , cilt.17, 2026 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

2. Evaluation of inflammatory parameters and ferritin as prognostic factors in non-small cell lung cancer patients receiving nivolumab immunotherapy: Prognostic inflammatory biomarkers in NSCLC immunotherapy

Beypınar İ., Balçık O. Y., Urvay S., Ürün M., Erçek B., Demir H., et al.
Biomarkers , 2026 (SCI-Expanded, Scopus) identifier identifier

3. Prognostic Significance of C-PLAN Index in Patients Treated with Immunotherapy for Non-Small-Cell Lung Cancer

NURANSOY CENGİZ A., BOZKURT O., Cengiz M., ÖZKAN M., İNANÇ M., KEFELİ U., et al.
Journal of Clinical Medicine , cilt.15, sa.2, 2026 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

4. Impact of renin–angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non–small cell lung cancer

Mutlu Ozkan E., Karadağ I., Sahın E., NURANSOY CENGİZ A., Cengız M., Can Guven D., et al.
Expert Review of Anticancer Therapy , 2026 (SCI-Expanded, Scopus) identifier identifier

5. Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer

Sezgin Y., Karhan O., Aldemir M. N., Ürün M., Erçek B. M., Urakcı Z., et al.
Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded, Scopus) identifier identifier

6. Comparison of Doublet and Triplet Chemotherapy Regimens in Geriatric Patients with Metastatic Gastric Cancer

YILMAZ ÜRÜN Y., DİRİK Y., DÜZEN OFLAS N., GÜNER G., CESUR S., ÜRÜN M.
Eskisehir Medical Journal, Eskisehir City Hospital , cilt.6, sa.2, ss.75-80, 2025 (TRDizin) identifier

7. Are they all the same? Different effects of opioid types on survival in metastatic NSCLC receiving nivolumab.

Balçık O. Y., Beypınar İ., Urvay S., Ürün M., Erçek B., Yıldız C., et al.
American journal of cancer research , cilt.15, sa.6, ss.2794-2806, 2025 (SCI-Expanded) identifier

8. Vincamine Mitigates Methotrexate-Induced Liver Fibrosis Model.

Ürün Y., Güner G., Bora E. S., Taşkın A. B., Ürün M., Erbaş O.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.36, sa.10, ss.641-648, 2025 (SCI-Expanded, Scopus, TRDizin) identifier identifier

9. Evaluation of second-line treatment options in metastatic esophageal squamous cell carcinoma

YILMAZ ÜRÜN Y., ÜRÜN M.
Journal of Current Hematology & Oncology Research , cilt.3, sa.2, ss.27-31, 2025 (Hakemli Dergi)

10. Prognostic value of IMDC score in non-small cell lung cancer receiving immunotherapy: old dog, new tricks?: IMDC in lung cancer immunotherapy

Beypınar İ., Urvay S., Ürün M., Erçek B., Demir H., Yıldız C., et al.
European Journal of Clinical Pharmacology , cilt.81, sa.4, ss.561-570, 2025 (SCI-Expanded, Scopus) identifier identifier

11. Response: Do Nutritional and Inflammatory Indices Predict Response in Geriatric Gastric Cancer Patients Treated With Neoadjuvant FLOT Regimen?

Ürün Y., Ürün M.
Cancer control : journal of the Moffitt Cancer Center , cilt.32, 2025 (SCI-Expanded, Scopus) identifier identifier

12. A Comparative Analysis of The Efficacy And Safety of Cisplatin and Oxaliplatin-Based Chemotherapy Regimens İn Elderly Patients With Metastatic Gastric Cancer

Ürün M., Kara M.
Eastern Journal of Medicine , cilt.30, sa.1, ss.63-68, 2025 (Scopus, TRDizin) Creative Commons License identifier identifier

13. Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study

Sahin T. K., Atalah F., Koylu B., Oruc A., Acarbay A., Karakok A., et al.
Frontiers in Immunology , cilt.16, 2025 (SCI-Expanded, Scopus) identifier identifier

14. The Role of Bıomarkers In Predıctıng Neoadjuvant Treatment Response In Gastrıc Cancer

Sezgin Y., Ürün M.
Eastern Journal of Medicine , cilt.30, sa.2, ss.245-255, 2025 (Scopus, TRDizin) Creative Commons License identifier identifier

15. Do Nutritional and Inflammatory Indices Predict Response in Geriatric Gastric Cancer Patients Treated with Neoadjuvant FLOT Regimen?

Ürün Y., Ürün M.
Cancer control : journal of the Moffitt Cancer Center , cilt.32, 2025 (SCI-Expanded, Scopus) identifier identifier

16. Positive Lymph Node Ratio as a new prognostic score in Geriatric patients with operated gastric cancer

Acar O., Balcik O. Y., Ürün M., Avci T., Sahbazlar M., Erdogan A. P.
Heliyon , cilt.10, sa.19, 2024 (SCI-Expanded, Scopus) identifier identifier

17. Prognostic Significance of the Advanced Lung Cancer Inflammation Index in Metastatic Small Cell Lung Cancer: A Retrospective Analysis of 96 Patients

Ürün M., Güner G., Sezgin Y., Uysal E., SAKİN A., Kilickap S.
Medical Science Monitor , cilt.30, 2024 (SCI-Expanded, Scopus) identifier identifier

18. COVID-19 PANDEMİSİNİN PALYATİF BAKIM MERKEZİNDEKİ KANSER HASTALARI ÜZERİNDEKİ ETKİSİNİN DEĞERLENDİRİLMESİ; ÖNCESİ & SONRASI

Kaya Z. I., Beypınar İ., Ürün M.
Kocatepe Tıp Dergisi , cilt.25, sa.3, ss.384-389, 2024 (TRDizin) identifier

19. Testis Kanserinde Prognostik Faktörler

Sezgin Y., Karhan O., Biçer A., İleri S., Yerlikaya H., Tunç S., et al.
Turkish Journal of Clinics and Laboratory , cilt.15, sa.2, ss.176-181, 2024 (TRDizin) Creative Commons License identifier

20. Comparison of efficacy and tolerability of single agent and double agent chemotherapy regimens in first-line treatment of elderly patients with HER-2 negative metastatic gastric cancer

GÜNER G., ÜRÜN M.
Journal of Current Hematology Oncology Research , cilt.2, sa.1, ss.15-19, 2024 (Hakemli Dergi)

21. Association Between Body Mass Index and Survival in Patients with De Novo Metastatic Non-Small Cell Lung Cancer

Ürün M., Güner G., Sezgin Y., SAKİN A., Kılıçkap S.
Medical Science Monitor , cilt.30, 2024 (SCI-Expanded, Scopus) identifier identifier

22. Evaluation of the healing and protective properties of adipose-derived mesenchymal stem cells from cisplatin-induced liver and kidney damage

Ürün M., Bora E., Acar H., Erbas O.
European Review for Medical and Pharmacological Sciences , cilt.28, sa.4, ss.1327-1339, 2024 (SCI-Expanded, Scopus) identifier identifier

23. Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric Cancer

Alkan A., Mizrak D., Yaşar A., Karci E., KÖKSOY E. B., Ürün M., et al.
Journal of Cancer Research and Therapeutics , cilt.20, sa.3, ss.913-917, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

24. PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

Avcı O., İriağaç Y., Çavdar E., Karaboyun K., Araz M., Şakalar T., et al.
Journal of Geriatric Oncology , cilt.14, sa.8, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

25. The impact of timing adjuvant therapy on disease-free survival among patients with stage iib-iiia non-small cell lung cancer receiving platinum- based treatment

ÜRÜN M., SEZGİN Y., UYSAL E.
Turkish Journal of Clinics and Laboratory , cilt.14, sa.3, ss.639-644, 2023 (TRDizin) identifier

26. Comparison of the Efficacy of FOLFIRI and Paclitaxel Chemotherapy Regimens in the Second Line Treatment of Metastatic Gastric Cancer

ÜRÜN M., GÜNER G., SEZGİN Y., YILMAZ ÜRÜN Y., SAKİN A.
Van Yuzuncu Yil University , cilt.16, sa.2, ss.176-182, 2023 (Hakemli Dergi)

27. ADDITIONAL COST OF OVERWEIGHT IN MEDICATION OF CANCER PATIENTS

ÜRÜN M., SEZGİN Y., YILMAZ ÜRÜN Y., UÇAN A., GÜRCÜ S., TUĞRUL F.
Eskisehir Medical Journal, Eskisehir City Hospital , cilt.4, sa.2, ss.107-110, 2023 (Hakemli Dergi)

28. The Comparison of FLOT vs. mDCF Regimens in Neoadjuvant Setting for Locally-advanced Gastric Cancer

ÜRÜN M., ŞAHİN S., YILMAZ ÜRÜN Y., SAKİN A.
Eurasian Journal of Medical Investigation , cilt.7, sa.3, ss.274-282, 2023 (TRDizin) identifier

29. Kanser hastalarında aşılanma durumu ve aşılanmayı etkileyen faktörlerin değerlendirilmesi

ÜRÜN M., BEYPINAR İ., DAVARCI S. E., DEMİR H., BAYKARA M.
ACTA MEDICA ALANYA , cilt.6, 2022 (TRDizin) identifier

30. Hepatobiliary System Effects And Clinical Features of Sars-Cov-2 Infection; Case-Control Study

YALINBAŞ KAYA B., YILMAZ ÜRÜN Y., YENİLMEZ İ., MERT KANTAR Y., TÜREYEN A., HAMARAT H., et al.
Eskisehir Medical Journal, Eskisehir City Hospital , cilt.3, sa.2, ss.157-166, 2022 (Hakemli Dergi)

31. Long-term effects of Covid-19 pandemic on oncology patients

ÜRÜN M., BEYPINAR İ.
Eurasian Journal of Medical Investigation , 2022 (TRDizin)

32. The Relatıonshıp Between Pet Ct And Tumor Features In Patıents Wıth Breast Cancer

SEZGİN Y., KARHAN O., İLERİ S., EBİNÇ S., BİLEN E., ÜRÜN M., et al.
Van Tıp Dergisi , cilt.29, 2022 (TRDizin) identifier

33. The Effects of Insulin Therapy on Fetuin-A Levels in Type-2 Diabetic Patients

ÜRÜN M., YILMAZ ÜRÜN Y., SAHİP B., ŞENTOSUN U.
Medical Journal of Western Black Sea , cilt.4, 2020 (TRDizin) identifier

34. Intravenous chemotherapy adherence of cancer patients in time of covid-19 crisis

Beypinar I., Urun M.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.30, sa.3, ss.133-138, 2020 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier

35. Vaccination in oncology practice and predictors

Alkan A., Karcı E., Yaşar A., Tuncay G., KÖKSOY E. B., Ürün M., et al.
Supportive Care in Cancer , cilt.25, sa.9, ss.2677-2682, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

36. Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients

Alkan A., Yaşar A., Karcı E., KÖKSOY E. B., Ürün M., Şenler F. Ç., et al.
Supportive Care in Cancer , cilt.25, sa.1, ss.229-236, 2017 (SCI-Expanded, Scopus) identifier identifier

37. Metabolik Sendromlu Hastalarda İnsülin Direnciyle Doku Faktör Yolu İnhibitörü (TFPI) Arasındaki İlişki

OMMA T., YILMAZ ÜRÜN Y., yiğit n., ÜRÜN M., KOLDAŞ M., ulusoy m., et al.
Smyrna Tıp Dergisi , 2014 (Hakemli Dergi)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 6

1. Dermatomiyozit ve Primeri Bilinmeyen Tümör Birlikteliği

ÜRÜN M.
3. Ankara Hematoloji ve Onkoloji Günleri, Ankara, Türkiye, 3 - 05 Şubat 2023, (Tam Metin Bildiri)

2. Yaygın Evre Küçük Hücreli Akciger Kanserinde Platelet Lenfosit Oranının Sag Kalımla Iliskisi

ÜRÜN M.
2. AKCİĞER KANSERİ SEMPOZYUMU 2022, İstanbul, Türkiye, 11 - 12 Haziran 2022, ss.19, (Özet Bildiri)

3. MEME KANSERI BASVURU SEKILLERI TEK MERKEZ VERISI

ÜRÜN M.
7.karadeniz onkoloji günleri-mentörlerle onkolojide yeni tedavilere bakış, Trabzon, Türkiye, 24 - 27 Mart 2022, (Özet Bildiri)

4. İLK SERİ TEDAVİDE PLATİN VE GEMSİTABİN VERİLEN METASTATİK PANKREAS KANSERİ HASTALARINDA ALBÜMİN GLOBÜLİN ORANININ SAĞ KALIMA ETKİSİ

ÜRÜN M.
3. eskişehir onkoloji günleri, Eskişehir, Türkiye, 11 - 13 Mart 2022, (Tam Metin Bildiri)

5. FAZLA KİLONUN HER-2 POZİTİF MEME KANSERİ HASTALARINDA 1 YILLIK EK MALİYET ANALİZİ

ÜRÜN M.
2. ULUSAL MEME KANSERİ SEMPOZYUMU 2022, İstanbul, Türkiye, 4 - 06 Şubat 2022, (Özet Bildiri)

6. The Effects of Platin Choice on Survival in Geriatric Patients with Non-Small Cell Lung Cancer

ÜRÜN M.
INTERNATIONAL CONGRESS ON BIOLOGICAL AND HEALTH SCIENCES, Eskişehir, Türkiye, 26 - 28 Ocak 2021, ss.210-211, (Özet Bildiri)
Kitaplar 4

1. Mavi Akrep Zehiri (Rhopalurus Junceus)

ÜRÜN M.
Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler, SAKİN ABDULLAH, Editör, akademisyen kitapevi, Ankara, ss.377-380, 2024

2. KANSER HASTALARINDA PSİKİYATRİK BAKIM

MERMİT ERÇEK B., ÜRÜN M.
GENEL TIPTA PSKİYATRİ, GÜZEL ÖZDEMİR PINAR, SÜNNETÇİOĞLU AYSEL, Editör, NOBEL KİTAPEVİ, Ankara, ss.153-167, 2023

3. Santral Sinir Sistemi Tümörleri Tedavisinde İmmünoterapi

ÜRÜN M.
ONKOLOJİDE İMMÜNOTERAPİ, Çelik ismail, Sedef ali murat, Editör, akademisyen kitapevi, ss.313-319, 2020

4. Pankreas Kanserlerinde Hedefe Yönelik Tedaviler

ÜRÜN M.
Onkolojide Moleküler Hedefli Tedaviler, sedef ali murat, Editör, Akademisyen Kitabevi, ss.221-224, 2020